×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
Click Here to View the Flyer in Japanese
Online Registration has been closed. Onsite Registration will be available at TKP Tokyo Station Yaesu Conference Center.
Program Committee
-
Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Rie Fujita Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takeshi Hamaura, PhD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan -
Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Motonori Kidokoro, PhD Director, Regulatory Affairs CMC
Daiichi Sankyo Pharma Development, United States -
Hitomi Koro Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yuko Nagai Manager, Regulatory Affairs Office, Quality & Pharmacovigilance Division
Nippon Kayaku Co., Ltd., Japan -
Yoshio Nakayama Regulatory Scientist, CM&C Regulatory Affairs, Japan Regulatory Affairs
Eli Lilly Japan K.K., Japan -
Hiroko Shibata Senior Researcher, Division of Drugs
National Institute of Health Sciences, Japan -
Yutaka Takahashi Senior Manager, Pharmaceutical Planning & Control
Astellas Pharma Inc., Japan -
Satomi Yagi Reviewer, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yukio Hiyama, PhD Visiting Researcher
National Institute of Health Sciences, Japan
Have an account?